Movement Alert|Edwards Lifesciences Intraday Rise 3.27% in Regular Trading, Q3 Beat and Piper Sandler Price Target Increase Support Shares

Market Focus11-05

On November 5, Edwards Lifesciences rose 3.27% in Regular Trading, trading at $103.03 per share, with turnover of $48.06 million.

The move followed stronger-than-expected third-quarter results and a same-day price target increase from Piper Sandler to $115 from $101.

Edwards Lifesciences reported adjusted EPS of $0.80 for the third quarter, above the $0.74 consensus, on revenue of $1.72 billion versus the $1.68 billion expectation. For the fourth quarter, the company guided to adjusted EPS of $0.61 to $0.69 on revenue of $1.67 billion to $1.75 billion, while its full-year adjusted EPS outlook was narrowed to $2.97 to $3.05 from $2.95 to $3.05 previously. Separately, the stock’s average analyst rating remained overweight, and the mean price target moved up to $111.04.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment